Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Marcus Soto, n/a
Sr Principal Scientist
Amgen Inc.
Poster(s):
(M0930-10-58) Protein Engineering Strategies to Overcome High Target-Independent Clearance of Monoclonal Antibodies Due to Charge-Driven Liabilities
Monday, October 21, 2024
9:30 AM – 10:30 AM
MT
